ВОЗМОЖНОСТИ ПРИМЕНЕНИЯ СЛЮНЫ ДЛЯ ДИАГНОСТИКИ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ

Аннотация

Применение слюны в клинической лабораторной диагностике является перспективным, а также неинвазивным, простым и недорогим метод для выявления ряда заболеваний. Интеграция комплекса методов, включая исследование генома, эпигенома, транскриптома, протеома, метаболома и микробиома, позволяет обнаружить и количественно определить ряд биомаркеров в слюне. Исследование слюны относится к неинвазивным методам и проводится для оценки возрастного и физиологического статуса, выявления соматических заболеваний, патологии слюнных желёз и тканей полости рта, генетических маркёров, мониторинга лекарственных средств и др. В настоящем обзоре рассмотрены последние данные по применению слюны для диагностики онкологических заболеваний.

Об авторах

Список литературы

Кочурова Е.В. Диагностические возможности слюны. Клиническая лабораторная диагностика. 2014; 1: 13-6

Kaur J., Jacobs R., Huang Y., Salvo N., Politis C. Salivary biomarkers for oral cancer and pre-cancer screening: a review. Clinical Oral Investigations. 2018. https://doi.org/10.1007/s00784-018-2337-x

Nair S., Tang K.D., Kenny L., Punyadeera C. Salivary exosomes as potential biomarkers in cancer. Oral Oncology. 2018; 84: 31-40.

Porto-Mascarenhas E.C., Assad D.X., Chardin H., Gozal D., De Luca Canto G., Acevedo A.C., Guerra E.N.S. Salivary biomarkers in the diagnosis of breast cancer: A review. Critical Reviews in Oncology/Hematology. 2017; 110: 62-73.

Spielmann N., Wong D.T. Saliva: diagnostics and therapeutic perspectives. Oral Diseases. 2011; 17: 345-54.

Zhang Y., Sun J., Lin C., Abemayor E., Wang M.B., Wong D. The Emerging Landscape of Salivary Diagnostics. OHDM. 2014; 13 (2): 200-10.

Wong D.T. Salivaomics. Journal of the American Dental Association. 2012; 143: 19S-24S.

Looi M.L., Zakaria H., Osman J., Jamal R. Quantity and quality assessment of DNA extracted from saliva and blood. Clinical Laboratory. 2012; 58: 307-12.

Bonne N.J., Wong D.T. Salivary biomarker development using genomic, proteomic and metabolomic approaches. Genome Medicine. 2012; 4: 82.

Carvalho A.L., Henrique R. Jeronimo C., Nayak C.S., Reddy A.N., et al. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Clinical Cancer Research. 2011; 17: 4782-9.

Bryan A.D., Magnan R.E., Hooper A.E., Harlaar N., Hutchison K.E. Physical activity and differential methylation of breast cancer genes assayed from saliva: a preliminary investigation. Annals of Behavioral Medicine. 2013; 45: 89-98.

Momen-Heravi F., Trachtenberg A.J., Kuo W.P., Cheng Y.S. Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer. J Dent Res. 2014; 93 (7): 86S-93S.

Brinkmann O., Wong D.T. Salivary transcriptome biomarkers in oral squamous cell cancer detection. Adv Clin Chem. 2011; 55: 21-34.

Lee Y.H., Zhou H., Reiss J.K., Yan X., Zhang L., et al. Direct saliva transcriptome analysis. Clinical Chemistry. 2011; 57: 1295-1302.

Zhang L., Xiao H., Zhou H., Santiago S., Lee J.M., Garon E.B., Yang J., Brinkmann O., Yan X., Akin D., Chia D., Elashoff D., Park N-H., Wong D.T.W. Development of transcriptomic biomarker signature in human saliva to detect lung cancer. Cellular and Molecular Life Sciences. 2012; 69 (19): 3341-50.

Lee Y.H., Kim J. H., Zhou H., Kim B.W., Wong D.T. Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma. Journal of Molecular Medicine. 2012; 90 (4): 427-34.

Li F., Yoshizawa J.M., Kim K.M., Kanjanapangka J., Grogan T.R., Wang X., Elashoff D.E., Ishikawa S., Chia D., Liao W., Akin D., Yan X., Lee M.S., Choi R., Kim S.M., Kang S.Y., Bae J.M., Sohn T.S., Lee J.H., Choi M.G., Min B.H., Lee J.H., Kim J.J., Kim Y., Kim S., Wong D.T.W. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer. Clin Chem. 2018; 64(10): 1513-21.

Matse J.H., Yoshizawa J., Wang X., Elashoff D., Bolscher J.G.M., Veerman E.C.I., Bloemena E., Wong D.T.W. Discovery and Prevalidation of Salivary Extracellular microRNA Biomarkers Panel for the Noninvasive Detection of Benign and Malignant Parotid Gland Tumors. Clinical Cancer Research. 2013; 19(11): 3032-8.

Jagtap P., McGowan T., Bandhakavi S., Tu Z.J., Seymour S., Griffin T.J., Rudney J.D. Deep metaproteomic analysis of human salivary supernatant. Proteomics. 2012; 12(7): 992-1001.

Loo J.A., Yan W., Ramachandran P., et al. Comparative human salivary and plasma proteomes. J Dent Res. 2010; 89: 1016-23.

Goswami Y., Mishra R., Agrawal A.P., Agrawal L.A. Salivary Biomarkers-A Review of Powerful Diagnostic tool. IOSR Journal of Dental and Medical Sciences. 2015; 14 (3): 80-7.

Schulz B.L., Cooper-White J., Punyadeera C.K. Saliva proteome research: current status and future outlook. Critical Reviews in Biotechnology. 2013; 33: 246-59.

Xiao H., Wong D.T. Method development for proteome stabilization in human saliva. Analytica Chimica Acta. 2012; 722: 63-9.

Alejandro I. Lorenzo-Pouso, Mario Pérez-Sayáns, Susana B. Bravo, Pía López-Jornet, María García-Vence, Manuela Alonso-Sampedro, Javier Carballo, Abel García-García. Protein-Based Salivary Profiles as Novel Biomarkers for Oral Diseases. Dis Markers. 2018; 6141845. doi: 10.1155/2018/6141845

Franzmann E.J., Reategui E.P., Pereira L.H., Pedroso F., Joseph D., Allen G.O., Hamilton K., Reis I., Duncan R., Goodwin W.J., Hu J.J., Lokeshwar V.B. Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma. Head Neck. 2012; 34 (5): 687-895.

Zhang A., Sun H., Wang P., Han Y., Wang X. Recent and potential developments of bio fluid analyses in Metabolomics. Journal of Proteomics. 2012; 75: 1079-88.

Ishikawa S., Sugimoto M., Kitabatake K., Sugano A., Nakamura M., Kaneko M., Ota S., Hiwatari K., Enomoto A., Soga T., Tomita M., Iino M. Identification of salivary metabolomic biomarkers for oral cancer screening. Scientific Reports. 2016; 6:31520.

Grimaldi M., Palisi A., Rossi G., Stillitano I., Faiella F., Montoro P., Rodriquez M., Palladino R., D’Ursi A.M., Romano R. Saliva of patients affected by salivary gland tumour: An NMR metabolomics analysis. Journal of Pharmaceutical and Biomedical Analysis. 2018; 160: 436-42.

Wei J., Xie G., Zhou Z., Shi P., Qiu Y., et al. Salivary metabolite sigNatures of oral cancer and leukoplakia. International Journal of Cancer. 2011; 129: 2207-17.

Guerra E.N.S., Acevedo A.C., Leite A.F., Gozal D., Chardin H., De Luca Canto G. Diagnostic capability of salivary biomarkers in the assessment of head and neck cancer: A systematic review and meta-analysis. Oral Oncology. 2015; 51(9): 805-18.

Burne R.A., Zeng L., Ahn S.J., Palmer S.R., Liu Y., et al. Progress dissecting the oral microbiome in caries and health. Advances in Dental Research. 2012; 24: 77-80.

Schwabe R.F., Jobin C. The microbiome and cancer. Nature Reviews Cancer. 2013; 13: 800-12.

Acharya A., Chan Y., Kheur S., Jin L.J., Watt R.M., Mattheos N. Salivary microbiome in non-oral disease: A summary of evidence and commentary. Archives of Oral Biology. 2017; 83: 169-73.

Yoshizawa J.M., Schafer C.A., Schafer J.J., Farrell J.J., Paster B.J., et al. Salivary biomarkers: toward future clinical and diagnostic utilities. Clinical Microbiology Reviews. 2013; 26: 781-791.

Hu X., Zhang Q., Hua H., Chen F. Changes in the salivary microbiota of oral leukoplakia and oral cancer. Oral Oncol. 2016; 56: e6-e8.

Farrell J.J., Zhang L., Zhou H., Chia D., Elashoff D., et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012; 61: 582-8.

Malathi N., Mythili S. and Vasanthi H.R. Salivary Diagnostics: A Brief Review. ISRN Dentistry. 2014, Article ID 158786, 8 pages. https://dx.doi.org/10.1155/2014/158786

Tang H., Wu Z., Zhang J., Su B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Molecular Medicine Reports. 2013; 7 (3): 761-6.

Yoshizawa J. M., Wong D.T.W. Salivary microRNAs and oral cancer detection. Methods in Molecular Biology. 2013; 936: 313-24.

De Abreu Pereira D., Areias V.R., Franco M.F., Benitez M.C.M., do Nascimento C.M., de Azevedo C.M., Alves G. Measurement of HER2 in Saliva of Women in Risk of Breast Cancer. Pathol. Oncol. Res. 2013; 19: 509-13.

Xiao H., Zhang L., Zhou H., Lee J.M., Garon E.B., Wong D.T. Proteomic analysis of human saliva from lung cancer patients using twodimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics. 2012; 11(2): 111-21.

Agha-Hosseini F., Mirzaii-Dizgah I., Rahimi A. Correlation of serum and salivary CA15-3 levels in patients with breast cancer. Med Oral Patol Oral Cir Bucal. 2009; 14: 521-4.

Balan J.J., Rao R.S., Premalatha B.R., Patil S. Analysis of tumor markers CA 125 in saliva of normal and oral squamous cell carcinoma patients: a comparative study. The Journal of Contemporary Dental Practice. 2012; 13 (5): 671-5.

Huang Y.Q., Li Y.D., Li G.K., Jin Z., Ma J. The evaluation of basic fibroblast growth factor and fibroblastic growth factor receptor 1 levels in saliva and serum of patients with salivary gland tumor. DNA and Cell Biology. 2012; 31 (4): 520-3.

Shiiki N., Tokuyama S., Sato C. et al. Association between saliva PSA and serum PSA in conditions with prostate adenocarcinoma. Biomarkers. 2011; 16 (6): 498-503.

Bernabe D.G., Tamae A.C., Miyahara G.I., Sundefeld M.L., Oliveira S.P., Biasoli E. R. Increased plasma and salivary cortisol levels in patients with oral cancer and their association with clinical stage. Journal of Clinical Pathology. 2012; 65 (10): 934-9.

Shetty S. R., Chadha R., Babu S., Kumari S., Bhat S., and Achalli S. Salivary lactate dehydrogenase levels in oral leukoplakia and oral squamous cell carcinoma: a biochemical and clinic pathological study. Journal of Cancer Research and Therapeutics. 2012; 8 (2): 123-5.

Rai B., Kaur J., Jacobs R., Anand S.C. Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue. Clinical Oral Investigations. 2011; 15 (3): 347-9.

Saxena V., Yadav N.S., Juneja V., Singh A., Tiwari V., Santha B. Saliva: a miraculous biofluid for early detection of disease. J. Oral Health Comm. Dent. 2013; 7(1): 64-8.

Кушлинский Н.Е., Любимова Н.В. Опухолевые маркеры. Общая характеристика, клинической значение и рекомендации по использованию. Поликлиника. 2016; 8: 62-77

Ключевые слова